NEW STEP BY STEP MAP FOR METHYLATION PROFILE TEST

Other biologically based limits of EpiSign analysis could be highlighted via the four inconclusive samples in the clinical testing cohort. The existing BAFopathy episignature is trained on optimistic conditions with pathogenic variants in ARID1B, ARID1A, SMARCB1, SMARCA2, and SMARCA4.17 as a result, it's not possible to completely rule out pathogen